DE69201451T2 - Thiazolidinone und Oxazolidenonederivate, ihre Herstellung und ihre Anwendung als Vasodilatatoren. - Google Patents

Thiazolidinone und Oxazolidenonederivate, ihre Herstellung und ihre Anwendung als Vasodilatatoren.

Info

Publication number
DE69201451T2
DE69201451T2 DE69201451T DE69201451T DE69201451T2 DE 69201451 T2 DE69201451 T2 DE 69201451T2 DE 69201451 T DE69201451 T DE 69201451T DE 69201451 T DE69201451 T DE 69201451T DE 69201451 T2 DE69201451 T2 DE 69201451T2
Authority
DE
Germany
Prior art keywords
oxazolidenone
thiazolidinones
vasodilators
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69201451T
Other languages
English (en)
Other versions
DE69201451D1 (de
Inventor
Sadao Ishihara
Fujio Saito
Takao Yoshioka
Hiroyuki Koike
Sigeki Miyake
Hiroshi Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69201451D1 publication Critical patent/DE69201451D1/de
Publication of DE69201451T2 publication Critical patent/DE69201451T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DE69201451T 1991-03-27 1992-03-27 Thiazolidinone und Oxazolidenonederivate, ihre Herstellung und ihre Anwendung als Vasodilatatoren. Expired - Fee Related DE69201451T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6308891 1991-03-27
JP10275191 1991-05-08
JP33030491 1991-12-13

Publications (2)

Publication Number Publication Date
DE69201451D1 DE69201451D1 (de) 1995-03-30
DE69201451T2 true DE69201451T2 (de) 1995-10-12

Family

ID=27298042

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69201451T Expired - Fee Related DE69201451T2 (de) 1991-03-27 1992-03-27 Thiazolidinone und Oxazolidenonederivate, ihre Herstellung und ihre Anwendung als Vasodilatatoren.

Country Status (23)

Country Link
US (2) US5298516A (de)
EP (1) EP0506434B1 (de)
JP (1) JPH0780859B2 (de)
KR (1) KR0152097B1 (de)
CN (2) CN1031824C (de)
AT (1) ATE118770T1 (de)
AU (1) AU647599B2 (de)
CA (1) CA2064108C (de)
CZ (1) CZ282529B6 (de)
DE (1) DE69201451T2 (de)
DK (1) DK0506434T3 (de)
ES (1) ES2072095T3 (de)
FI (1) FI106260B (de)
HK (1) HK123595A (de)
HU (2) HU217969B (de)
IE (1) IE67383B1 (de)
IL (1) IL101395A (de)
IS (1) IS1746B (de)
NO (1) NO304311B1 (de)
NZ (1) NZ242154A (de)
PH (1) PH30493A (de)
RU (1) RU2055073C1 (de)
TW (1) TW226015B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
WO1994021248A1 (de) * 1993-03-15 1994-09-29 Byk Nederland Bv Verwendung von substituierten alkylnitraten zur behandlung des krankhaft erhöhten augeninnendruckes
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ATE203987T1 (de) * 1994-12-15 2001-08-15 Sankyo Co Thiazolidonon- oder oxazolidinonderivate zur behandlung von angina pectoris und zusammensetzungen die diese als wirkstoffe enthält
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
NZ302391A (en) * 1995-03-02 1999-04-29 Sankyo Co Optically active thiazolidinone derivatives having vessel dilating and an anti-angina pectoris action and use thereof as pharmaceuticals
AU6016496A (en) * 1995-06-14 1997-01-15 Sankyo Company Limited Antianginal drug comprising nitroxy derivative as active ingredient
BE1010768A3 (nl) * 1996-11-26 1999-01-05 Dsm Nv Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan.
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
WO2002069967A1 (fr) * 2001-03-01 2002-09-12 Sankyo Company, Limited Compositions a absorption percutanee
CA2842106A1 (en) * 2011-07-28 2013-01-31 Promentis Pharmaceuticals, Inc. Cysteine prodrugs
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
EP0469061A1 (de) * 1989-04-21 1992-02-05 E.I. Du Pont De Nemours And Company Fungizide oxazolidinone

Also Published As

Publication number Publication date
JPH0780859B2 (ja) 1995-08-30
HK123595A (en) 1995-08-04
AU647599B2 (en) 1994-03-24
NO921159D0 (no) 1992-03-25
IS1746B (is) 2000-07-11
HU217969B (hu) 2000-05-28
ATE118770T1 (de) 1995-03-15
JPH05213910A (ja) 1993-08-24
AU1312292A (en) 1992-10-01
KR0152097B1 (ko) 1998-10-15
CZ91692A3 (en) 1993-01-13
HU9201033D0 (en) 1992-06-29
KR920018036A (ko) 1992-10-21
CZ282529B6 (cs) 1997-08-13
US5298516A (en) 1994-03-29
CN1113435A (zh) 1995-12-20
CN1031824C (zh) 1996-05-22
CA2064108A1 (en) 1992-09-28
FI921340A (fi) 1992-09-28
IL101395A (en) 1996-10-16
CN1096265C (zh) 2002-12-18
HUT68242A (en) 1995-06-28
ES2072095T3 (es) 1995-07-01
NZ242154A (en) 1993-09-27
TW226015B (de) 1994-07-01
NO304311B1 (no) 1998-11-30
CN1066067A (zh) 1992-11-11
FI106260B (fi) 2000-12-29
FI921340A0 (fi) 1992-03-26
RU2055073C1 (ru) 1996-02-27
IL101395A0 (en) 1992-11-15
PH30493A (en) 1997-05-28
NO921159L (no) 1992-09-28
EP0506434B1 (de) 1995-02-22
HU211969A9 (en) 1996-01-29
US5356918A (en) 1994-10-18
IE67383B1 (en) 1996-03-20
CA2064108C (en) 2000-09-26
EP0506434A1 (de) 1992-09-30
DE69201451D1 (de) 1995-03-30
IE920966A1 (en) 1992-10-07
IS3828A (is) 1992-09-28
DK0506434T3 (da) 1995-07-24

Similar Documents

Publication Publication Date Title
DE69030147D1 (de) 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo[7.2.0.0.3,8]undec-2-en-2-carbonsäure-Derivate
DE69316068D1 (de) 1-[2-(Arylsulfonylamino)-1-oxoethyl]piperidin-Derivate, ihre Herstellung und therapeutische Verwendung
DE69505968D1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
DE69201451D1 (de) Thiazolidinone und Oxazolidenonederivate, ihre Herstellung und ihre Anwendung als Vasodilatatoren.
DE69215694D1 (de) Benzamid-derivate
ATE174593T1 (de) Neue bisoxadiazolidinderivate
ATE2219T1 (de) Phenyl-piperazin-derivate, ihre herstellung und sie enthaltende anti-agressive heilmittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee